Indivior Pharmaceuticals (INDV) Other financing activities (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Other financing activities of $3.0 million for Q1 2026, up 400.0% quarter-over-quarter from -$1.0 million in Q1 2024.
Indivior Pharmaceuticals (INDV) Other financing activities (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Other financing activities history runs 2 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (changed N/A YoY), while the FY2024 annual figure was -$2.0 million, changed N/A from the prior year.
- Other financing activities for Q1 2026 stood at $3.0 million, up from -$1.0 million in the prior quarter.
- The five-year high for Other financing activities was $3.0 million in Q1 2026, with the low at -$1.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Mar 31, 2024 | -1.00 Mn |